PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of cytotechspringer.comThis journalToc AlertsSubmit OnlineOpen Choice
 
Cytotechnology. 2009 April; 59(3): 209.
Published online 2009 August 2. doi:  10.1007/s10616-009-9221-0
PMCID: PMC2774572

Suppression of growth of highly-metastatic human breast cancer cells by norcantharidin and its mechanisms of action

Erratum to: Cytotechnology DOI 10.1007/s10616-009-9210-3

In the original version of this article, in the “Materials and methods” section, under the subsection “Animal experimentation and preparation of sera from NCTD-treated rabbits”, the third sentence currently reads:

‘NCTD was given via the intravenous injection to the rabbits once daily at a dose of 10 mg mL−1 100 g−1 body weight for 3 days’

Should read:

‘NCTD was given via the intravenous injection to the rabbits once daily at a dose of 1 mg 0.2 mL−1 kg −1 body weight for 3 days’.

Footnotes

The online version of the original article can be found under doi:10.1007/s10616-009-9210-3.


Articles from Cytotechnology are provided here courtesy of Springer Science+Business Media B.V.